Table 3.
Hip RCT outcomes and their mapping to the three core and one optional OMERACT areas/domains
| Authors | Pathophysiological | Life impact | Death | All 3 core areas reported | Resource use/economic impacta | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pain | Stiffness | ROM | AE | Blood loss | RSA | RMAL | Satisfaction | Hip QoL | General QoL | Function | Activity levels | Mortality | LoI | Surgery time | LoS | Reop/readmit | Revision rate | ||
| Garcia-Rey 2008 [20] | √ | √ | √ | √ | |||||||||||||||
| Glyn-Jones 2008a [21] | √ | √ | √ | √ | |||||||||||||||
| Glyn-Jones 2008b [22] | √ | √ | |||||||||||||||||
| Hamadouche 2008 [23] | √ | √ | √ | √ | √ | √ | √ | √ | |||||||||||
| Lachiewicz 2008 [24] | √ | √ | √ | √ | √ | √ | |||||||||||||
| Macaulay 2008 [25] | √ | √ | √ | √ | √ | √ | √ | √ | |||||||||||
| Meneghini 2008 [26] | √ | √ | |||||||||||||||||
| Mouzopoulos 2008 [27] | √ | √ | √ | √ | √ | ||||||||||||||
| Pagnano 2008 [28] | √ | √ | √ | √ | |||||||||||||||
| Pitto 2008 [29] | √ | √ | √ | √ | |||||||||||||||
| Barrett 2013 [30] | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | |||||||||
| Bjorgul 2013 [31] | √ | √ | √ | √ | √ | √ | √ | √ | √ | ||||||||||
| Cadossi 2013 [32] | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | ||||||||
| Desmarchelier 2013 [33] | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | |||||||||
| Greidanus 2013 [34] | √ | √ | √ | √ | √ | √ | √ | ||||||||||||
| Hedbeck 2013 [35] | √ | √ | √ | √ | √ | √ | |||||||||||||
| Inngul 2013 [36] | √ | √ | √ | √ | √ | √ | √ | √ | |||||||||||
| Kim 2013 [37] | √ | √ | √ | √ | √ | √ | √ | √ | |||||||||||
| Landgraeber 2013 [38] | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | ||||||||
| Munzinger 2013 [39] | √ | ||||||||||||||||||
| Naudie 2013 [40] | √ | √ | √ | √ | √ | √ | √ | √ | |||||||||||
| Penny 2013 [41] | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | ||||||||
| Smolders 2013 [42] | √ | √ | |||||||||||||||||
| Stiehler 2013 [43] | √ | √ | √ | √ | √ | √ | |||||||||||||
| Venditolli 2013 [44] | √ | √ | √ | ||||||||||||||||
| Vidovic 2013 [45] | √ | √ | √ | √ | √ | √ | √ | ||||||||||||
| Zagra 2013 [46] | √ | √ | √ | ||||||||||||||||
11 RCTs had all three core areas reported
AE adverse events, RSA radiosteriometric analysis, RMAL radiographs to measure alignment or loosening, Satis satisfaction, QoL quality of life, LoI length of incision, LoS length of stay
aArea/domain recommended, but not a core area